Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Herbert Works Ltd. has received its Health Canada research and development (R&D) license to develop branded…
Digital marketing and consumer data management technology company SRAX (NASDAQ: SRAX) today announced its entry into new partnerships with major consumer packaged goods (“CPG”) brands to launch BIG Rewards(TM). According to the update, BIG Rewards(TM)…
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its class A subordinated voting shares began trading on the Toronto Stock Exchange (the “TSX”) under the…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products,…
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its receipt of Health Canada approval, effective September 6, 2019, for the licensing of…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced the successful completion of its master collaborative research agreement with the National Research Council of Canada (“NRC”) focused…
Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced that it has received final approval to list its class A subordinated voting shares on the Toronto Stock Exchange…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) on Tuesday issued an update regarding its clinical development programs, manufacturing and strategy for bringing its Oncoprex(TM) immunogene therapy to market. A corporate presentation is available on GNPX’s…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today commented on the recent transaction between Aurora Cannabis (TSX: ACB) and a syndicate of Canadian banks. Per the update, the…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced its receipt of Health Canada approval, under the Cannabis Regulations, to expand operations into its new Hamilton, Ontario-based hybrid…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games and toys in China, today announced that its CEO Xiaodong Chen rang the Nasdaq opening bell at…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered definitive agreements to acquire ABI SF, LLC. ABI SF operates a Bay Area cannabis…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, recently received coverage in a Bloomberg article discussing OGI’s financial results for the last four quarters (http://ibn.fm/BUMhB).…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, recently reported financial results for the second quarter ended June 30, 2019 (http://ibn.fm/shHin). An…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced the closing of its acquisition of Henderson Organic Remedies, LLC (“The+Source Henderson”), which was previously disclosed on December 14, 2018. According to the…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced that 4,207,083 common share purchase warrants began trading on the Canadian Securities Exchange (“CSE”) under the symbol ‘TCAN.WT’ as the market opened today. The warrants, each…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its receipt of a new patent granted in Australia: #2016367037 / Grant Date August 15, 2019 – “Stable…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning reported financial results for the first quarter ended June 30, 2019. Among other highlights, the company reported an operating income of $2.7 million for the quarter which…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life-sciences and other industries, recently executed a contract services agreement with a well-known biotherapeutics…